THERAPEUTICS
Review: medication adjustment based on fractional exhaled nitric oxide did not prevent asthma exacerbations
| The first 150 words of the full text of this article appear below. |
H Petsky
Ms H Petsky, Royal Children's Hospital, Brisbane, Queensland, Australia; helen_petsky@health.qld.gov.au
QUESTION
In adults and children with asthma, does medication adjustment based on fractional exhaled nitric oxide (FeNO) concentration prevent asthma exacerbations more than adjustment based on clinical symptoms?
REVIEW SCOPE
Included studies compared adjustment of asthma medication based on FeNO concentrations with adjustment based on clinical symptoms (with or without spirometry) in adults or children with "classical" asthma. Outcomes were asthma exacerbations, symptom scores, and final and cumulative dose of inhaled corticosteroids.
REVIEW METHODS
Cochrane Airways Group Specialised Register of Trials, Cochrane Central Register of Controlled Trials (Issue 4, 2006), Medline and EMBASE/Excerpta Medica (to Dec 2006), Old Medline (1950–65), and references were searched for randomised controlled trials (RCTs). Authors of included trials were consulted. 4 RCTs (n = 356) met the selection criteria: 2 RCTs in children (n = 141, mean age 12 y, 63% boys), 1 RCT in adults (n =
Queen Elizabeth Hospital Woodville, South Australia, Australia
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
